Literature DB >> 11420329

Paracetamol overdose in a preterm neonate.

G K Isbister1, I K Bucens, I M Whyte.   

Abstract

The first oral overdose of paracetamol in a neonate is reported. A 55 day old neonate, born 29 weeks premature, was accidentally given 136 mg/kg paracetamol. Treatment was with activated charcoal, supportive care, and N-acetylcysteine. There was no biochemical evidence of hepatotoxicity, and no long term sequelae. After modelling of the data, the following pharmacokinetic variables were calculated: absorption half life (t(abs)), 0.51 hours; volume of distribution (V/F(oral)), 0.80 litres/kg; clearance (CL/F(oral)), 0.22 litres/h; they were consistent with population pharmacokinetic studies. The increased plasma half life (Tbeta) of 5.69 hours thus reflected normal slower metabolism in infants, rather than toxicity. The toxicity of paracetamol in neonates is unclear, but appears to be low because of slow oxidative metabolism and rapid glutathione synthesis. In an overdose, estimates of toxicity can be made from dose and Tbeta in neonates, or from maternal toxicity in transplacental poisoning. Treatment includes N-acetylcysteine and supportive care, with activated charcoal for oral poisoning.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11420329      PMCID: PMC1721264          DOI: 10.1136/fn.85.1.f70

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  11 in total

Review 1.  Lack of toxicity after paracetamol overdose in a extremely preterm neonate.

Authors:  Roser Porta; Lara Sánchez; Marta Nicolás; Carmen García; Marta Martínez
Journal:  Eur J Clin Pharmacol       Date:  2012-01-07       Impact factor: 2.953

Review 2.  Paracetamol overdose in the newborn and infant: a life-threatening event.

Authors:  Cristian Locci; Laura Cuzzolin; Giampiero Capobianco; Roberto Antonucci
Journal:  Eur J Clin Pharmacol       Date:  2021-01-03       Impact factor: 2.953

Review 3.  Oral medications regarding their safety and efficacy in the management of patent ductus arteriosus.

Authors:  Mehmet Yekta Oncel; Omer Erdeve
Journal:  World J Clin Pediatr       Date:  2016-02-08

Review 4.  Racing against time: leveraging preclinical models to understand pulmonary susceptibility to perinatal acetaminophen exposures.

Authors:  David J McCulley; Erik A Jensen; Jennifer M S Sucre; Sarah McKenna; Laura G Sherlock; Evgenia Dobrinskikh; Clyde J Wright
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-05-03       Impact factor: 6.011

Review 5.  Nonsteroidal anti-inflammatory agents in neonates.

Authors:  John L Morris; David A Rosen; Kathleen R Rosen
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

6.  Incorrect prescription of intravenous paracetamol in a pediatric patient.

Authors:  E Orün; A Polat; H Andan; N Cizmeci; N Tufan
Journal:  Hippokratia       Date:  2013-01       Impact factor: 0.471

7.  Paracetamol serum concentrations in preterm infants treated with paracetamol intravenously: a case series.

Authors:  Christ-Jan Jlm van Ganzewinkel; Thilo Mohns; Richard A van Lingen; Luc Jj Derijks; Peter Andriessen
Journal:  J Med Case Rep       Date:  2012-01-04

8.  Acute liver failure in a term neonate after repeated paracetamol administration.

Authors:  Fábio Bucaretchi; Carla Borrasca Fernandes; Maíra Migliari Branco; Eduardo Mello De Capitani; Stephen Hyslop; Jamil Pedro S Caldas; Carolina Araújo Moreno; Gilda Porta
Journal:  Rev Paul Pediatr       Date:  2014-03

Review 9.  Clinical pharmacology of paracetamol in neonates: a review.

Authors:  Gian Maria Pacifici; Karel Allegaert
Journal:  Curr Ther Res Clin Exp       Date:  2014-12-12

Review 10.  Paracetamol in Patent Ductus Arteriosus Treatment: Efficacious and Safe?

Authors:  Flaminia Bardanzellu; Paola Neroni; Angelica Dessì; Vassilios Fanos
Journal:  Biomed Res Int       Date:  2017-07-30       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.